Baru nuts reduce abdominal adiposity in type 2 diabetic adults: a randomized, placebo-controlled, crossover trial

Author:

Cruvinel Beatriz Assis Carvalho1ORCID,Alves Ana Gabriella Pereira2ORCID,Schincaglia Raquel Machado2ORCID,Silva Maria Sebastiana2ORCID

Affiliation:

1. Universidade Federal de Jataí, Brasil

2. Universidade federal de Goiás, Brasil

Abstract

ABSTRACT Objective: This study aimed to evaluate the effect of baru nuts supplementation on body composition and metabolic profile in adults with type 2 diabetes. Methods: This is a randomized, placebo-controlled, crossover trial with 30 adults with type 2 diabetes. The assay had two periods of 12 weeks each, with a washout period of 12 weeks between treatments. The subjects were randomized and received the two treatments in alternate periods: supplementation of 30g baru nuts or placebo. Anthropometry, body composition, blood pressure, blood sampling, food intake, and physical activity data were analyzed. Results: Baru nut intake reduced waist circumference (p=0.032), compared to placebo group. In the intra-group analysis, baru nut intake reduced total cholesterol (p=0.012) and LDL-c (p=0.017). Conclusion: The daily intake of baru nuts improved abdominal adiposity. Therefore, these nuts should be included in the diet to improve the health status of adults with type 2 diabetes.

Publisher

FapUNIFESP (SciELO)

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Reference38 articles.

1. IDF Diabetes Atlas 2021,2021

2. From the triumvirate to the ominous octet: a new paradigm for the treatment of Type 2 Diabetes Mellitus;DeFronzo AR.;Diabetes.,2009

3. Nutritional quality and protein value of exotic almonds and nut from the Brazilian Savanna compared to peanut;Oliveira Sousa AG;Food Res Int.,2011

4. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes;Esser N;Diabetes Res Clin Pract.,2014

5. A comparative study of lipid profile, body mass index, and waist circumference among Type 2 diabetes mellitus patients with poor and good metabolic control and normal age-matched control group;Menon S;Natl J Physiol Pharm Pharmacol.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3